rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Stephen Hoge

President

Company insider

Files Form 4 as: President, Moderna; Director, Axcella Health.

Every Form 4 they filed

In numbers

Trades disclosed
1,080
Buys
0
Sells
206
Bought
$0
Sold
$369.7M
Companies
2
Companies where not an officer
1
First trade
11 Dec 2018
Last trade
15 Oct 2026
Last filed
16 Oct 2026

Companies traded

Where they are an officer
MRNA ModernaOfficer · Biotechnology · last 15 Oct 20260 buys · 206 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Axcella HealthDirector · last 20 May 20210 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Oct 2026filed 16 Oct 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$933K76,452 at $12.21filing
15 Oct 2026filed 16 Oct 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$8.6M39,145 at $220.72filing
15 Oct 2026filed 16 Oct 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—76,452 at $0.00filing
14 Oct 2026filed 16 Oct 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$933K76,453 at $12.21filing
14 Oct 2026filed 16 Oct 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$8.3M38,774 at $213.47filing
14 Oct 2026filed 16 Oct 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$96K450 at $214.15filing
14 Oct 2026filed 16 Oct 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—76,453 at $0.00filing
15 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$933K76,452 at $12.21filing
15 Sep 2026filed 16 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—76,452 at $0.00filing
15 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$5.9M40,281 at $146.07filing
15 Sep 2026filed 16 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—76,452 at $0.00filing
15 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$933K76,452 at $12.21filing
15 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$5.9M40,281 at $146.07filing
14 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$933K76,453 at $12.21filing
14 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$5.8M40,294 at $144.13filing
14 Sep 2026filed 16 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—76,453 at $0.00filing
14 Sep 2026filed 16 Sep 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—76,453 at $0.00filing
14 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$933K76,453 at $12.21filing
14 Sep 2026filed 16 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$5.8M40,294 at $144.13filing
1 Sep 2026filed 3 Sep 2026MRNA ModernaBiotechnologySEC FORM 4 Code M—9,283filing

The newest 500 lines are listed; the numbers count every line.

Sectors

Health Care206

Buys in green, sells in red, by the company’s sector.

Related people

James M. MockChief Financial Officer · Chief Financial Officer at Moderna, filing Form 4 there in the last year
Shannon Thyme KlingerChief Legal Officer · Chief Legal Officer at Moderna, filing Form 4 there in the last year
Stephane BancelChief Executive Officer · Chief Executive Officer at Moderna, filing Form 4 there in the last year
Michael R. McDonnellDirector · Director at Moderna, filing Form 4 there in the last year
Soria Ester BanqueChief Commercial Officer · Chief Commercial Officer at Moderna, filing Form 4 there in the last year
Maria Elvira SalazarRepresentative, FL-27 · Also traded MRNA in the last 90 days
Donald J. TrumpPresident · Also traded MRNA in the last 90 days